BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16258369)

  • 21. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.
    Sharer N; Schwarz M; Malone G; Howarth A; Painter J; Super M; Braganza J
    N Engl J Med; 1998 Sep; 339(10):645-52. PubMed ID: 9725921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthy Chinese with benign pancreatic hyperenzymemia.
    Yang BL; Wu WC; Su CW; Wu JC; Yeh C; Lee SD
    J Chin Med Assoc; 2015 Oct; 78(10):623-6. PubMed ID: 26271549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and morphological characteristics of sporadic genetically determined pancreatitis as compared to idiopathic pancreatitis: higher risk of pancreatic cancer in CFTR variants.
    Hamoir C; Pepermans X; Piessevaux H; Jouret-Mourin A; Weynand B; Habyalimana JB; Leal T; Geubel A; Gigot JF; Deprez PH
    Digestion; 2013; 87(4):229-39. PubMed ID: 23751316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease.
    Ventrucci M; Gullo L; Daniele C; Bartolucci C; Priori P; Platé L; Bonora G; Labò G
    Digestion; 1983; 28(2):114-21. PubMed ID: 6197334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of pancreatitis with mutation of the cystic fibrosis gene.
    Choudari CP; Imperiale TF; Sherman S; Fogel E; Lehman GA
    Am J Gastroenterol; 2004 Jul; 99(7):1358-63. PubMed ID: 15233679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis.
    Tzetis M; Kaliakatsos M; Fotoulaki M; Papatheodorou A; Doudounakis S; Tsezou A; Makrythanasis P; Kanavakis E; Nousia-Arvanitakis S
    Clin Genet; 2007 May; 71(5):451-7. PubMed ID: 17489851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of cystic fibrosis transmembrane conductance regulator in patients with chronic sinopulmonary disease.
    Gonska T; Choi P; Stephenson A; Ellis L; Martin S; Solomon M; Dupuis A; Dorfman R; Zielenski J; Ooi CY; Weiser W; Durie PR; Tullis E
    Chest; 2012 Oct; 142(4):996-1004. PubMed ID: 22423042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Frequency of CFTR gene mutations in idiopathic pancreatitis].
    Maire F; Bienvenu T; Ngukam A; Hammel P; Ruszniewski P; Lévy P
    Gastroenterol Clin Biol; 2003 Apr; 27(4):398-402. PubMed ID: 12759680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life in patients with long-standing chronic non-pathological pancreatic hyperenzymemia.
    Pezzilli R; Brighi N; Calculli L
    Pancreatology; 2015; 15(2):131-5. PubMed ID: 25708931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis.
    Audrézet MP; Chen JM; Le Maréchal C; Ruszniewski P; Robaszkiewicz M; Raguénès O; Quéré I; Scotet V; Férec C
    Eur J Hum Genet; 2002 Feb; 10(2):100-6. PubMed ID: 11938439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.
    Cuppens H; Lin W; Jaspers M; Costes B; Teng H; Vankeerberghen A; Jorissen M; Droogmans G; Reynaert I; Goossens M; Nilius B; Cassiman JJ
    J Clin Invest; 1998 Jan; 101(2):487-96. PubMed ID: 9435322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.
    Malats N; Casals T; Porta M; Guarner L; Estivill X; Real FX
    Gut; 2001 Jan; 48(1):70-4. PubMed ID: 11115825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amylase, pancreatic isoamylase and lipase in serum before and after endoscopic pancreatography.
    Fjøsne U; Waldum HL; Romslo I; Kleveland PM; Johnsen H; Engebretsen LF
    Acta Med Scand; 1986; 219(3):301-4. PubMed ID: 2422881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Extrapancreatic hyperamylasemia. Diagnostic value of isoamylase and lipase determination].
    Satz N; Jacot des Combes A; Deubelbeiss T; Ott A; Knoblauch M
    Schweiz Med Wochenschr; 1989 Feb; 119(7):209-16. PubMed ID: 2469125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of serum pancreatic enzymes in acute alcohol intoxication and acute alcoholic pancreatitis.
    Pezzilli R; Billi P; Barakat B; Fiocchi M; Miglio F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):174-8. PubMed ID: 9646200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Benign pancreatic hyperenzynemia or Gullo's syndrome].
    Gullo L; Lucrezio L; Bassi M; Nesticò V; Migliori M
    Recenti Prog Med; 2008; 99(7-8):367-71. PubMed ID: 18751616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of serum amylase pancreatic isoamylase and lipase in patients with hyperamylasemia.
    Kolars JC; Ellis CJ; Levitt MD
    Dig Dis Sci; 1984 Apr; 29(4):289-93. PubMed ID: 6200276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A proinflammatory, antiapoptotic phenotype underlies the susceptibility to acute pancreatitis in cystic fibrosis transmembrane regulator (-/-) mice.
    Dimagno MJ; Lee SH; Hao Y; Zhou SY; McKenna BJ; Owyang C
    Gastroenterology; 2005 Aug; 129(2):665-81. PubMed ID: 16083720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
    Ooi CY; Durie PR
    J Cyst Fibros; 2012 Sep; 11(5):355-62. PubMed ID: 22658665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
    Sharma H; Mavuduru RS; Singh SK; Prasad R
    Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.